Paul Lizzul

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ANAB

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Anaptysbio, Inc (ANAB)	Chief Medical Officer	$545,754	—	$505,703	$1,064,476	$221,031	$28,413	$2,365,377
2024	Anaptysbio, Inc (ANAB)	Chief Medical Officer	$529,859	—	$2,128,976	$1,741,973	$158,958	$23,742	$4,583,508
2023	Anaptysbio, Inc (ANAB)	Chief Medical Officer	$509,479	—	$570,993	$1,131,250	$203,792	$25,603	$2,441,117
2022	Anaptysbio, Inc (ANAB)	Chief Medical Officer	$471,740	—	$283,440	$2,872,730	$174,544	$10,074	$3,812,528
2021	Anaptysbio, Inc (ANAB)	Chief Medical Officer	$458,000	—	—	$1,015,911	$216,357	$8,810	$1,699,078
2020	Anaptysbio, Inc (ANAB)	Chief Medical Officer	$168,205	—	—	$1,238,769	$67,507	$104,238	$1,578,719

No earnings-call appearances or filed executive changes recorded yet.